These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Should we be 'pushing meds'? The implications of pharmacogenomics. Bray J; Clarke C; Brennan G; Muncey T J Psychiatr Ment Health Nurs; 2008 Jun; 15(5):357-64. PubMed ID: 18454820 [TBL] [Abstract][Full Text] [Related]
24. Pharmacogenomics in Alzheimer's disease. Cacabelos R Methods Mol Biol; 2008; 448():213-357. PubMed ID: 18370236 [TBL] [Abstract][Full Text] [Related]
26. Neurotransmitter receptor variants and their influence on antipsychotic treatment (Review)). Arranz MJ; Mancama D; Kerwin RW Int J Mol Med; 2001 Jan; 7(1):27-30. PubMed ID: 11115604 [TBL] [Abstract][Full Text] [Related]
27. Pharmacogenomics and therapeutic strategies for dementia. Cacabelos R Expert Rev Mol Diagn; 2009 Sep; 9(6):567-611. PubMed ID: 19732004 [TBL] [Abstract][Full Text] [Related]
28. Pharmacogenomics of statin responsiveness. Kajinami K; Akao H; Polisecki E; Schaefer EJ Am J Cardiol; 2005 Nov; 96(9A):65K-70K; discussion 34K-35K. PubMed ID: 16291017 [TBL] [Abstract][Full Text] [Related]
29. Prevalence of patients using drugs metabolized by cytochrome P450 2D6 in different populations: a cross-sectional study. Mulder H; Heerdink ER; van Iersel EE; Wilmink FW; Egberts AC Ann Pharmacother; 2007 Mar; 41(3):408-13. PubMed ID: 17341534 [TBL] [Abstract][Full Text] [Related]
30. Evolution of pharmacogenomics. Somogy A Proc West Pharmacol Soc; 2008; 51():1-4. PubMed ID: 19544663 [TBL] [Abstract][Full Text] [Related]
31. Genomics and the future of pharmacotherapy in psychiatry. Malhotra AK; Lencz T; Correll CU; Kane JM Int Rev Psychiatry; 2007 Oct; 19(5):523-30. PubMed ID: 17896232 [TBL] [Abstract][Full Text] [Related]
32. Pharmacogenomic discovery approaches: will the real genes please stand up? Walgren RA; Meucci MA; McLeod HL J Clin Oncol; 2005 Oct; 23(29):7342-9. PubMed ID: 16145062 [TBL] [Abstract][Full Text] [Related]
33. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
34. CYP450 pharmacogenetics for personalizing cancer therapy. van Schaik RH Drug Resist Updat; 2008 Jun; 11(3):77-98. PubMed ID: 18486526 [TBL] [Abstract][Full Text] [Related]
35. Pharmacogenetics in HIV therapy. Rodríguez-Nóvoa S; Barreiro P; Jiménez-Nacher I; Rendón A; Soriano V AIDS Rev; 2005; 7(2):103-12. PubMed ID: 16092504 [TBL] [Abstract][Full Text] [Related]
36. Pharmacogenomics and serotonergic agents: research observations and potential clinical practice implications. Camilleri M Neurogastroenterol Motil; 2007 Aug; 19 Suppl 2():40-5. PubMed ID: 17620087 [TBL] [Abstract][Full Text] [Related]
37. Polymorphism of human cytochrome P450 enzymes and its clinical impact. Zhou SF; Liu JP; Chowbay B Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967 [TBL] [Abstract][Full Text] [Related]
38. Pharmacogenomics in psychiatry: the relevance of receptor and transporter polymorphisms. Reynolds GP; McGowan OO; Dalton CF Br J Clin Pharmacol; 2014 Apr; 77(4):654-72. PubMed ID: 24354796 [TBL] [Abstract][Full Text] [Related]
39. Pharmacogenetics for the individualization of psychiatric treatment. Arranz MJ; Collier D; Kerwin RW Am J Pharmacogenomics; 2001; 1(1):3-10. PubMed ID: 12173312 [TBL] [Abstract][Full Text] [Related]
40. Pharmacogenetics, race, and psychiatry: prospects and challenges. Jones DS; Perlis RH Harv Rev Psychiatry; 2006; 14(2):92-108. PubMed ID: 16603475 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]